News

DGX stock rises on a new partnership with MD Anderson to develop a blood test targeting multiple cancer risks.
B RYAN, Texas (KBTX) - With his family alongside, Roy Lopez toured his brand-new home Friday evening, about 24 hours after learning he was the 2025 Bryan/College Station St. Jude Dream Home winner. He ...
Why You Should Consider a Regular Fitness Routine During This Time. It's a lot to deal with the emotional and physical ...
The International Agency for Research on Cancer forecasts over 35 million new cancer cases in 2050 globally. The growing ...
Treating patients with lung cancer always calls for a focus on informed and shared decision-making, according to expert ...
Quest plans to refine, develop and validate the technology and is aiming to launch the test in North America next year.
You may have heard that moderate intensity exercise — even brisk walking — may be linked to a 37% reduction in risk of death ...
More people under 50 are getting appendix cancer. Here's what to know about this type of cancer, as well as why case rates ...
Expert oncologists Dr. Joshua K. Sabari and Dr. Eric K. Singhi break down key updates and takeaways in lung cancer treatment following ASCO 2025.
The clinical lab giant is working with MD Anderson on an LDT for assessing cancer risk to drive uptake of recommended screenings and identify high-risk individuals for evaluation.
Practitioners in each profession detail the speed of regulatory challenges and changes, emphasize the importance of keeping ...
Mailed self-collection (SC) kits may increase participation in cervical cancer screening, according to a study published ...